#Perfusion System Market Share

[neha24blog]

Perfusion System Market Trends Analysis Report By Application, Region And Forecast To 2030 : Grand View Research Inc.

Perfusion System Market Trends Analysis Report By Application, Region And Forecast To 2030 : Grand View Research Inc.

San Francisco, 21 Nov 2022: The Report Perfusion System Market Size, Share & Trends Analysis Report By Application (Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-vivo Organ Perfusion System), By Region, And Segment Forecasts, 2022 – 2030 The global perfusion system market size is projected to reach USD 1.54 billion by 2030, according to a new report by Grand View Research, Inc.…

[themarketupdate]

Cardiac Output Monitoring Devices Market to Observe Strong Growth to Generate Massive Revenue in Coming Years

Cardiac output monitoring device is a tool to ensure tissue oxygenation which accomplished using the pulmonary artery catheter. The cardiac output monitor device allows to flow of blood to the tissue and provide information for failing circulation. The cardiac output monitoring device is used for high risk and critically ill surgical patient with whom large fluid shifts are expected along with bleeding and hemodynamic instability. The device used in conjunction with administration of fluid and vasopressors to achieve set therapeutic endpoints thereby improving patient care and outcome. The cardiac output monitor helps in cardiac function monitoring, providing an estimate of whole body perfusion oxygen delivery and allowing to understand the cause of high blood pressure.

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/2283-global-cardiac-output-monitoring-devices-sales-market?utm_source=Organic&utm_medium=Vinay

Latest released the research study on Global Cardiac Output Monitoring Devices Market, offers a detailed overview of the factors influencing the global business scope. Cardiac Output Monitoring Devices Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Cardiac Output Monitoring Devices The study covers emerging player’s data, including: competitive landscape, sales, revenue and global market share of top manufacturers are Edwards Lifesciences (United States), Medtronic Inc. (Ireland), GE Healthcare (United States), Abbott (United States), Biotronik (Germany), ICU Medical (United States), Vytech (India), LiDCO Group (United Kingdom), PULSION Medical Systems SE (Germany), Deltex Medical (England)

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Southeast Asia.

Contact Us:

Craig Francis (PR & Marketing Manager)

AMA Research & Media LLP

Unit No. 429, Parsonage Road Edison, NJ

New Jersey USA – 08837

sales@advancemarketanalytics.com

[businessindustry]

2032, Near-Infrared Fluorescence Imaging Systems Market Analysis by Reports and Insights

The Reports and Insights, a leading market research company, has recently releases report titled “Near-Infrared Fluorescence Imaging Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Near-Infrared Fluorescence Imaging Systems Market Analysis share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Near-Infrared Fluorescence Imaging Systems Market?

The global near-infrared fluorescence imaging systems market size reached US$ 1.4 billion in 2023. Looking forward, Reports and Insights expects the market to reach US$ 3.3 billion in 2032, exhibiting a growth rate (CAGR) of 10.1% during 2024-2032.

What are Near-Infrared Fluorescence Imaging Systems?

Near-infrared fluorescence imaging systems are cutting-edge medical imaging tools used to visualize structures and functions inside the body. They work by using near-infrared light to stimulate fluorescent contrast agents, which emit light that the imaging system detects. This technology enables high-resolution, real-time imaging of tissues, organs, and blood vessels during surgeries. Near-infrared fluorescence imaging systems are utilized across different medical disciplines, such as oncology, neurosurgery, and vascular surgery, to assist in visualizing, navigating, and evaluating tissue perfusion.

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/2028

What are the growth prospects and trends in the Near-Infrared Fluorescence Imaging Systems industry?

The near-infrared fluorescence imaging systems market growth is driven by various factors. The near-infrared fluorescence imaging systems market is witnessing significant growth, fueled by several factors including the increasing adoption of minimally invasive surgeries, advancements in imaging technologies, and the growing prevalence of chronic diseases. These systems provide real-time visualization of tissues, organs, and blood vessels, assisting surgeons in achieving improved surgical outcomes. Key drivers of market growth include the rising demand for accurate and early diagnosis, the expanding elderly population, and the widening applications of near-infrared fluorescence imaging in medical fields such as oncology, cardiovascular surgery, and plastic surgery. Moreover, the introduction of portable and cost-effective imaging systems is expected to further boost market expansion. Hence, all these factors contribute to near-infrared fluorescence imaging systems market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

By Product Type:

Handheld Devices

Standalone Devices

By Imaging Modality:

White Light Endoscopy

Near-Infrared Fluorescence Imaging

By Application:

Oncology

Cardiovascular

Gastrointestinal Surgery

Plastic/Reconstructive Surgery

Others

By End-Use:

Hospitals

Specialty Clinics

Research Institutes

Others

Segmentation By Region:

North America:

United States

Canada

Asia Pacific:

China

India

Japan

Australia New Zealand

Association of Southeast Asian Nations (ASEAN)

Rest of Asia Pacific

Europe:

Germany

The U.K.

France

Spain

Italy

Russia

Poland

BENELUX (Belgium, the Netherlands, Luxembourg)

NORDIC (Norway, Sweden, Finland, Denmark)

Rest of Europe

Latin America:

Brazil

Mexico

Argentina

Rest of Latin America

The Middle East Africa:

Saudi Arabia

United Arab Emirates

South Africa

Egypt

Israel

Rest of MEA (Middle East & Africa)

Who are the key players operating in the industry?

The report covers the major market players including:

Hamamatsu Photonics K.K.

Leica Microsystems (Danaher Corporation)

PerkinElmer, Inc.

Quest Medical Imaging B.V.

LI-COR Biosciences, Inc.

Fluoptics

Shimadzu Corporation

KARL STORZ SE Co. KG

Novadaq Technologies Inc. (acquired by Stryker Corporation)

SurgVision

Mizuho Corporation

Olympus Corporation

Carl Zeiss AG

Karl Kaps GmbH Co. KG

View Full Report: https://www.reportsandinsights.com/report/Near-Infrared Fluorescence Imaging Systems-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

Reports and Insights Business Research Pvt. Ltd. 1820 Avenue M, Brooklyn, NY, 11230, United States Contact No: +1-(347)-748-1518 Email: sales@reportsandinsights.com Website: https://www.reportsandinsights.com/ Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/ Follow us on twitter: https://twitter.com/ReportsandInsi1

[bhushans]

Cardiac Surgery Devices Market Insights: What to Expect by 2034

The  cardiac surgery devices market is on track for notable growth, with a projected valuation of USD 1.7 billion by the end of 2022. Over the next decade, the market is expected to expand at a compound annual growth rate (CAGR) of 3.6%, reaching approximately USD 2.4 billion by 2032. This growth is primarily fueled by the increasing prevalence of cardiovascular diseases worldwide.

In 2021, perfusion disposables led the market, commanding a significant demand share of about 59.1%. These disposables are critical components used in open-heart procedures to address various structural defects in the cardiovascular system. Key applications include coronary artery bypass grafting, congenital heart defect repairs, abdominal aortic aneurysm repair, ventricular remodeling, and cardiac assist device implantation.

Cardiac surgery devices, such as heart-lung machines, play an essential role in cardiothoracic surgery, particularly for performing cardiopulmonary bypasses. As cardiovascular diseases continue to pose major health challenges globally, the demand for these devices is expected to rise, driving market growth.

Get your PDF Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-4602

By encouraging the use of perfusion disposables, the market for cardiac surgical instruments is anticipated to gain from the rising popularity of heart-lung machine tables. Cardiovascular disease is the leading cause of death in the United States, contributing to over one-third of all deaths worldwide and 17 percent of US healthcare costs. According to American Heart Association forecasts, by 2030, 40% of Americans will suffer from cardiovascular sickness, with a direct cost of over $820 billion.

Well-developed Medical Infrastructure Makes North America Keep its Crown

North America has a world-class medical infrastructure coupled with a population that is rapidly ageing and suffering from cardiopulmonary disorders.

This combination all but ensures that the region is larger than both Western Europe and APEJ combined in the year 2017 with a value of just under US$ 555 Million.

North America is on track to witness a CAGR of 4.1% for the period 2017 to 2027 that should see the market in the region touch US$ 830 Million by end 2027.

Most new developments are centred in North America and its high acceptance of modern technology make it an extremely lucrative region in the global cardiac surgery devices market.

Minimally Invasive Surgery Gaining Traction in Cardiac Surgery Devices Market

Coronary artery bypass grafting is anticipated to be the largest contributor in the cardiac surgery devices market by procedure in 2017 and it is unlikely to cede this position anytime soon.

However, modern advancements in cardiopulmonary bypass techniques, surgical approaches and incisions have made minimally invasive surgery increasingly popular in recent times.

Minimally invasive surgery has the advantage of reduced surgical trauma and decreased pain and this is anticipated to propel the cardiac surgery devices market in the long term.

In terms of CAGR these two segments hold the top position in the global cardiac surgery devices market, with coronary artery bypass grafting recording a value CAGR of 3.5% and minimally invasive surgery registering a 4.1% CAGR in terms of revenue during the forecast period.

Focus on Hospitals over Ambulatory Surgical Centres in the Cardiac Surgery Devices Market

The hospitals segment is larger than the ambulatory surgical centres segment by end user in the cardiac surgery devices market and this trend is predicted to continue for the foreseeable future.

An attractiveness index of 1.1 and a market opportunity of almost US$ 1.2 Bn by 2027 end should make all major companies actively target the hospitals end user segment in the cardiac surgery devices market.

Company Dashboard:

The companies actively involved in the global cardiac surgery devices market that have been profiled in the report include Biotronik, Braile Biomedica, Cook Medical Inc., Estech, Abiomed, Smith Medical, MicroPort Scientific Corporation, Edwards Lifesciences Corporation, Angiodynamics, Teleflex Incorporated, C. R. Bard, Inc, B. Braun Melsungen AG, Getinge-Maquet Germany Holding GmbH, Terumo Corporation, LivaNova PLC, Lepu Medical technology Co ltd., Boston Scientific Corporation, Medtronic, and Abbott Laboratories.

Important takeaways:

The increasing preference for minimally invasive surgical procedures is one of the recent trends seen in the cardiac surgery devices market.

In the last decade, minimally invasive cardiothoracic surgery has grown by leaps and bounds mainly because of the reduced pain and surgical trauma after this procedure.

Even though coronary artery bypass grafting is much larger at present, key stakeholders are advised to focus on minimally invasive procedures as patients will almost certainly prefer this form of treatment.

In addition to this, the beating heart surgery system type could see widespread adoption in the days ahead.

Key Segments:

By Product:

Heart Lung Machine

Breathing Heart Surgery Systems

Stabilisers

Positioners

Catheters

Ablation Catheter

Drainage Catheter

Perfusion Disposables

Oxygenators

Centrifugal Pumps

Cardioplegia Delivery System

By End User:

Hospitals

Ambulatory Surgical Centres

By Procedure:

Coronary Artery Bypass Grafting

On pump CABG

Off pump CABG

Minimally Invasive Surgery

By Region:

North America

Latin America

Western Europe

Eastern Europe

APEJ

Japan

MEA

[blog-site-for-market-research]

Market Share Analysis of Albumin Market Services

Market Overview –

The albumin market revolves around the production, distribution, and utilization of albumin, a vital protein found in blood plasma. Human serum albumin (HSA) and bovine serum albumin (BSA) are the two primary types used in various medical, pharmaceutical, and biotechnological applications. Albumin serves diverse functions in the body, including maintaining osmotic pressure, transporting hormones and drugs, and regulating pH levels.

The albumin (as excipient) market size was estimated to be around USD 0.9 billion in 2022 and is expected to increase at a compound yearly growth rate (CAGR) of 5.9% from USD 0.95 billion in 2023 to USD 1.46 billion by 2032.

The albumin market centers on the production and distribution of albumin, a vital protein found in blood plasma that performs various functions such as maintaining osmotic pressure, transporting molecules, and regulating pH levels. Albumin is commonly used in pharmaceuticals, diagnostics, and research applications.

The albumin market, particularly emphasizing macroaggregated albumin, is witnessing steady growth. As a vital component in various medical applications, including diagnostics and therapeutics, albumin's demand remains high. Macroaggregated albumin plays a crucial role in nuclear medicine, particularly in lung perfusion scans. This specialized application contributes to the market's continued expansion and innovation.

Market growth is propelled by the increasing demand for albumin in medical treatments, including volume expansion therapy, drug delivery, and plasma protein replacement therapy for patients with liver diseases, burns, and other medical conditions. Albumin is also utilized in diagnostic tests and research experiments due to its unique properties and versatility.

Technological advancements and innovations in albumin purification, formulation, and storage methods are shaping the market, offering high-purity, stable, and cost-effective albumin products. From chromatography techniques and virus inactivation methods to lyophilization and nanotechnology-based formulations, these advancements improve albumin quality, safety, and shelf-life, meeting the diverse needs of healthcare providers and researchers.

Moreover, the COVID-19 pandemic has underscored the importance of albumin in critical care settings, as healthcare systems face challenges such as fluid resuscitation, hypoalbuminemia, and cytokine storms in severely ill patients. Albumin plays a crucial role in stabilizing blood volume, supporting organ function, and modulating inflammatory responses, driving market growth and innovation in the medical field.

However, challenges such as supply chain disruptions, regulatory constraints, and pricing pressures pose obstacles to market growth. Addressing these challenges requires collaboration between albumin manufacturers, regulatory agencies, and healthcare providers to ensure product safety, quality, and accessibility for patients in need.

Overall, the albumin market presents significant opportunities for innovation and collaboration to improve patient care and advance medical research. By investing in research, technology, and manufacturing capabilities, stakeholders can drive continued growth and advancement in the albumin market and contribute to better healthcare outcomes for individuals worldwide.

Segmentation –

The global albumin (as excipient) market is segmented based on type, application, end user, and region.

The global albumin (as excipient) market, by type is segmented into human serum albumin, bovine serum albumin, and recombinant albumin. The human serum albumin segment is anticipated to hold the largest market share owing to the increasing cases of chronic conditions such as, cardiac disorders, infectious diseases, and others.

Based on application, the market is segmented into drug formulation, drug delivery, vaccines, medical device coating, culture media & stabilizers, diagnostics, in vitro fertilization, and others.

Based on end user, the market is segmented into pharmaceutical & biotechnology industry, academic and research institutes, and others.

Regional Analysis –

Regional analysis of the albumin market reveals diverse trends and dynamics across different parts of the world. In North America, particularly in the United States and Canada, the albumin market is significant due to factors such as a large aging population, well-established healthcare infrastructure, and high demand for albumin in various medical applications.

The region witnesses a growing use of albumin in critical care settings, including treatment of shock, burns, and liver disease, as well as in therapeutic formulations and research. Europe showcases a mature albumin market, with countries like Germany, the UK, and France leading in terms of consumption and production.

The region benefits from stringent regulatory standards ensuring product quality and safety, along with a strong presence of leading albumin manufacturers. In the Asia-Pacific region, countries like China, India, and Japan are emerging as key players in the albumin market, driven by increasing healthcare expenditure, growing prevalence of chronic diseases, and expanding pharmaceutical and biotechnology sectors. Latin America exhibits significant growth potential in the albumin market, fueled by improving healthcare infrastructure and rising demand for blood products.

The Middle East and Africa region also experience a steady increase in albumin consumption, supported by expanding healthcare access and a growing focus on medical advancements. Understanding these regional dynamics is essential for albumin manufacturers and suppliers to develop targeted strategies, ensure market access, and meet the specific needs of diverse customer bases worldwide.

Key Players –

Albumin companies include Albumedix A/S, Albumin Therapeutics, LLC Baxalta Incorporated, Baxter International Inc., Biotest AG, CSL Behring LLC, China Biologic Products Inc., Grifols International, HiMedia Laboratories Pvt. Ltd., among others.

Related Reports –

Medical Tourniquets

Forensic Swab

Ascites

Intraoperative Neurophysiological Monitoring

For more information visit at MarketResearchFuture

[aeroautomotive]

Perfusion Systems Market Global Analysis and Forecasts by Solutions, Component, and Application to 2027

The “Global Perfusion Systems Market research report| Industry 2027 year” unveils cutting-edge market research findings. The Insight Partners is leading market research and consultation company is proud to announce the release of a comprehensive research report on the Perfusion Systems market. Leveraging advanced methodologies and cutting-edge technology Insight Partners has delved deep into market trends to deliver valuable insights for businesses seeking a competitive edge.

Key highlights of this market report:

Thorough Market Analysis-

Insight Partners has conducted an in-depth investigation of the Perfusion Systems market highlighting key drivers, challenges, and opportunities in the forecast period. Important contents analyzed in this report are key stats such as market size, market segments, revenue projections, and future market trends. This report offers subsegments information and includes information on all major countries and associations. This study further deep dives into market barriers and issues associated with cost and ROIs affecting Perfusion Systems market companies.

Empower Your Business| Request A Free Sample- https://www.theinsightpartners.com/sample/TIPMD00002293/

Consumer Behavior Insight

The report provides a nuanced understanding of changing consumer preferences, enabling businesses to tailor their strategies for maximum impact. It comprehensively covers key factors impacting the business with accurate future projections. Investors can make informed decisions based on unbiased market scenario coverage.

Competitive Landscape

The Insight Partners have meticulously mapped out the competitive terrain of the Perfusion Systems market, offering a clear picture of key market players, their market share, and potential collaborations. This section also provides insights into potential challenges companies might face in increasing competitiveness.

Technological Disruptions

This report covers insights into the role of technology in the transformation of the Perfusion Systems market. Covering the latest technological advancements this section attempts to guide business for Industry 4.0 transformations.

Global Market Outlook

This report offers a global and regional growth outlook for companies in the Perfusion Systems market. Key market players are- REPLIGEN CORPORATION, Merck KGaA, Ala Scientific Instruments, Inc., XVIVO Perfusion, Medtronic, XENIOS AG (Fresenius Medical Care AG & Co. KGaA), TERUMO CORPORATION, Getinge AB, Harvard Bioscience, OrganOx . This report aims to offer an understanding of the global market situation and identify key regions for growth in the future.

Strategic Recommendations

The Insight Partners presents actionable insights to empower businesses in making informed decisions based on industry evidence. These lucrative suggestions intend to offer our clients a competitive edge over their competitors.

Perfusion Systems Market Segmentation

Based on Type of Perfusion Systems Market Research report:

Microfluidic Perfusion Systems

Small-Mammal Organ Perfusion Systems

Bioreactor Perfusion Systems

gravity or Pressure-Driven Perfusion Systems

Based on Component of Perfusion Systems Market Research report:

Perfusion Pumps

Oxygenators

Herat-Lung Machines

Monitoring Systems

Cannulas

Based on Regions:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of Latin America)

The Middle East and Africa (Turkey, GCC, Rest of the Middle East and Africa)

Rest of the World…

Talk to Our Analyst and Explore more about Customization - sales@theinsightpartners.com

To Summarize the Key Highlights of this Report:

Market Estimates | Forecast Year

Market Dynamics – Drivers, Restraints, Opportunities, and Threats

Market Segmentation – Product Types, Application, and Regional Markets

Competitive Landscape – Top Market Participants and their Business Strategies.

About The Insight Partners:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Ankit Mathur E-mail: sales@theinsightpartners.comPhone: +1-646-491-9876

[healthcaremarketfmi]

Perfusion Imaging Market Growth, Latest Trends, Top Players, Competition, Technological Advancements, Outlook and Forecast 2032

The market for perfusion imaging is expected to grow from US$ 2.1 billion in 2022 to US$ 8.3 billion by 2032 as a result of the prevalence of neurological and cardiovascular diseases in the world.

According to FMI, during the forecast period from 2022 to 2032, the perfusion imaging market is expected to demonstrate the aforementioned growth at a CAGR of 6.8%.

Perfusion imagining helps in identifying nutritive blood supply to an element of tissue. Perfusion imaging techniques have the capability to generate both perfusion measurements and perfusion maps of the region of interest. In the perfusion imaging market, the application of such imaging techniques have been growing over the years. The market growth is primarily due to need for perfusion imaging for evaluating key body functions via assessing a number of functional and metabolic parameters.

The various perfusion imaging tools available in the market ranges from microspheres to computed tomography. These product tools help in mapping the blood through the brain’s vascular network. The market of perfusion imaging is expected to have a healthy CAGR over the forecast period due to continuous product lunch and demand for novel techniques to non-invasively measure various hemodynamic parameters.

Perfusion Imaging: Market Dynamics

The perfusion imaging market is anticipated to increase in the forecast period. It is anticipated that the growing demand for non-invasive therapies and treatment will drive the market of perfusion imaging in the forecast period. Rise in number of cardiovascular diseases, brain tumours, tumour-related angiogenesis etc. is also expected to drive the market of perfusion imaging market.

According to WHO, globally one billion people every year suffer from either one or many type of neurological disorders. Amongst these 50 million account for epilepsy and allied diseases where as 24 million suffer from Alzheimer. Prolonged sickness in neurological disorders results in 6.8 million death.  However, fast processing of perfusion imaging systems and tools which takes 60-75 seconds of time to image the circulation of blood supply helps in patient’s treatment process immensely.

Other recent developments in perfusion imaging market include new radioactive material with shorter life span. It reduces exposure of the patient to radioactive material. However high treatment cost, expensive devices and poor hi-tech healthcare penetration in lower income regions will restraint the growth of the perfusion imaging market.

Perfusion Imaging Market: Overview

Measurement of tissue perfusion imaging primarily depends on the performance and concentration of tracer agent in the target organ of interest. Nowadays, new and exogenous tracers are being used in Perfusion Imaging which are equally effective with lesser side effects. These include chilled saline solution, radio nucleotides and iodinated radiographic contrast material. With recent developments in MR imaging, both exogenous and endogenous tracer agents have been extensively used in the perfusion imaging market

For More Information: https://www.futuremarketinsights.com/reports/perfusion-imaging-market

Perfusion Imaging Market: Region-wise Outlook

North America will account for the largest share in global perfusion imaging market. Presence of manufacturing site of some of the key perfusion imaging product manufacturers is expected to generate regions revenue. European regions owing to aggressive healthcare infrastructure will also be leading revenue generating market after North America for perfusion imaging. East and South Asian countries along with some of the Latin American countries are expected to be the fastest growing perfusion imaging market in the forecast period due to these regions advancements in healthcare facilities and rise in annual per capita income.

GCC countries from Middle East and African region are also expected to show decent growth but some poor countries from region will negatively impact the global perfusion imaging market growth. It is believed lack of training sessions for operating the systems is the main reason for region’s poor market growth for perfusion imaging.

[neha24blog]

Perfusion Systems Market Demand By Application, Region And Forecast To 2030: Grand View Research Inc.

San Francisco, 29 Aug 2024: The Report Perfusion Systems Market Size, Share & Trends Analysis Report By Application (Cardiopulmonary Perfusion System, Cell Perfusion System), By Region (North America, Europe), And Segment Forecasts, 2024 – 2030 The global perfusion systems market size is projected to reach USD 1.55 billion by 2030, according to a new report by Grand View Research, Inc.…

[businessindustry]

2032, Near-Infrared Fluorescence Imaging Systems Market Analysis by Reports and Insights

The Reports and Insights, a leading market research company, has recently releases report titled “Near-Infrared Fluorescence Imaging Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Near-Infrared Fluorescence Imaging Systems Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Near-Infrared Fluorescence Imaging Systems Market?

The global near-infrared fluorescence imaging systems market size reached US$ 1.4 billion in 2023. Looking forward, Reports and Insights expects the market to reach US$ 3.3 billion in 2032, exhibiting a growth rate (CAGR) of 10.1% during 2024-2032.

What are Near-Infrared Fluorescence Imaging Systems?

Near-infrared fluorescence imaging systems are cutting-edge medical imaging tools used to visualize structures and functions inside the body. They work by using near-infrared light to stimulate fluorescent contrast agents, which emit light that the imaging system detects. This technology enables high-resolution, real-time imaging of tissues, organs, and blood vessels during surgeries. Near-infrared fluorescence imaging systems are utilized across different medical disciplines, such as oncology, neurosurgery, and vascular surgery, to assist in visualizing, navigating, and evaluating tissue perfusion.

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/2028

What are the growth prospects and trends in the Near-Infrared Fluorescence Imaging Systems industry?

The near-infrared fluorescence imaging systems market growth is driven by various factors. The near-infrared fluorescence imaging systems market is witnessing significant growth, fueled by several factors including the increasing adoption of minimally invasive surgeries, advancements in imaging technologies, and the growing prevalence of chronic diseases. These systems provide real-time visualization of tissues, organs, and blood vessels, assisting surgeons in achieving improved surgical outcomes. Key drivers of market growth include the rising demand for accurate and early diagnosis, the expanding elderly population, and the widening applications of near-infrared fluorescence imaging in medical fields such as oncology, cardiovascular surgery, and plastic surgery. Moreover, the introduction of portable and cost-effective imaging systems is expected to further boost market expansion. Hence, all these factors contribute to near-infrared fluorescence imaging systems market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

By Product Type:

Handheld Devices

Standalone Devices

By Imaging Modality:

White Light Endoscopy

Near-Infrared Fluorescence Imaging

By Application:

Oncology

Cardiovascular

Gastrointestinal Surgery

Plastic/Reconstructive Surgery

Others

By End-Use:

Hospitals

Specialty Clinics

Research Institutes

Others

Segmentation By Region:

North America:

United States

Canada

Asia Pacific:

China

India

Japan

Australia New Zealand

Association of Southeast Asian Nations (ASEAN)

Rest of Asia Pacific

Europe:

Germany

The U.K.

France

Spain

Italy

Russia

Poland

BENELUX (Belgium, the Netherlands, Luxembourg)

NORDIC (Norway, Sweden, Finland, Denmark)

Rest of Europe

Latin America:

Brazil

Mexico

Argentina

Rest of Latin America

The Middle East Africa:

Saudi Arabia

United Arab Emirates

South Africa

Egypt

Israel

Rest of MEA (Middle East & Africa)

Who are the key players operating in the industry?

The report covers the major market players including:

Hamamatsu Photonics K.K.

Leica Microsystems (Danaher Corporation)

PerkinElmer, Inc.

Quest Medical Imaging B.V.

LI-COR Biosciences, Inc.

Fluoptics

Shimadzu Corporation

KARL STORZ SE Co. KG

Novadaq Technologies Inc. (acquired by Stryker Corporation)

SurgVision

Mizuho Corporation

Olympus Corporation

Carl Zeiss AG

Karl Kaps GmbH Co. KG

View Full Report: https://www.reportsandinsights.com/report/Near-Infrared Fluorescence Imaging Systems-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

Reports and Insights Business Research Pvt. Ltd. 1820 Avenue M, Brooklyn, NY, 11230, United States Contact No: +1-(347)-748-1518 Email: sales@reportsandinsights.com Website: https://www.reportsandinsights.com/ Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/ Follow us on twitter: https://twitter.com/ReportsandInsi1

[meditech-insights]

Global Brain Monitoring Market is anticipated to raise at a CAGR of ~6-7% by 2026

Clinical neurological, neurophysiological, neuroradiological, ultrasound-based, and invasive monitoring of a patient's nervous system is referred to as brain monitoring. The aim of brain monitoring is to identify altered or pathological neurological function as soon as possible so that the appropriate treatment can be administered before irreversible harm occurs.

The Brain Monitoring Market is expected to grow at a rate of ~6-7% by 2026. Some of the major factors propelling the global brain monitoring market include the rising prevalence of neurological disorders, technological developments in brain monitoring devices, increased prevalence of traumatic brain injuries, rising demand for non-invasive and minimally invasive devices, increased use of brain monitoring in clinical trials, and expanding therapeutic applications of brain monitoring devices.

Growing Demand for Non-Invasive Brain Monitoring Techniques for Measuring Intracranial Pressure Drives the Market

Non-invasive monitoring methods provide a reliable alternative to invasive methods. ICP monitors, transcranial doppler, electroencephalogram, near-infrared spectroscopy, and other techniques are available and can be utilized in a variety of situations. Citing the growing demand for non-invasive techniques, several players have launched innovative products which are expected to propel the market in the coming years.

For instance,

In September 2021, NeuroWave Systems Inc. announced the FDA clearance of its NeuroSENSE® NS-901 Monitor

In August 2020, IRRAS AB announced the first patient treatment using the Hummingbird Solo

Increase in Usage of Electroencephalogram (EEG) for Diagnosing Neurological Disorder Propels the Brain Monitoring Market

An EEG is a test that detects abnormalities in brain waves or the brain’s electrical activity. The EEG is utilized to evaluate several types of brain disorders such as monitoring blood flow in the brain during surgical procedures determining the overall electrical activity of the brain, Alzheimer’s disease, certain psychosis, and a sleep disorder called narcolepsy, epilepsy, etc.

Explore Premium Report on Brain Monitoring Market @ https://meditechinsights.com/global-brain-monitoring-market/

Potential of Brain Monitoring Using Sensors, Wearables, and Mobile Devices Boost the Market

Rapid technological advances have been witnessed in the area of portable EEG monitoring, sleep assessment, gait analysis, cognitive function testing, eye tracking, and voice analysis.

For instance:

Interaxon Inc. launched the second generation of its popular EEG meditation & sleep headband, Muse S

NeuroSky developed ZenZone’s apps designed to receive feedback data from the body via a sensor, which helps the app understand the state of mind and body

Growing Adoption of Brain Multimodality Monitoring in Neurocritical Care of Comatose Patients Fuels the Demand

Neurocritical care patients are at risk of developing secondary brain injury. Multimodality monitoring (MMM) involves the use of a variety of tools to monitor changes in brain metabolism, perfusion, and oxygenation in order to modify therapy before irreversible injury occurs.

Key Constraints/ Challenges: Brain Monitoring Market

Some of the major factors that are anticipated to hamper the growth of the brain monitoring market are high costs associated with the complex brain monitoring procedures and devices, unfavorable reimbursement policies, and a shortage of trained professionals.

North America Holds the Largest Share in the Global Brain Monitoring Market

North America currently holds a major share in the global brain monitoring market. This can be mainly attributed to the growing adoption of technologically advanced brain monitoring devices, rising awareness regarding neurodegenerative disorders, and increasing applications in clinical trials in the region.

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Brain Monitoring Market

Players operating in the brain monitoring market are implementing organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner market share.

For instance,

In July 2022, Philips announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance for their SmartSpeed artificial intelligence (AI) powered MR acceleration software

In October 2021, Brain Scientific announced that they have received FDA Clearance for Next-Gen NeuroCap EEG Headset, an advanced Electroencephalogram (EEG) electrode array

Competitive Landscape Analysis of Brain Monitoring Market

Some of the key players operating in the global brain monitoring market include Natus Medical Inc., Nihon Kohden Corporation, Philips Healthcare, and Siemens Healthineers, among others.

For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com

[blog-site-for-market-research]

Global High Throughput Screening Market Size| Growth | Scope, 2032

Market Overview

The global high throughput screening market is expected to mature at a 7.5% CAGR during the forecast period.

Market Highlights

High throughput screening has achieved mainstream acceptance over the past two decades and has become a traditional drug discovery tool in the pharmaceutical industry. Factors such as technical developments in HTS and rising pharmaceutical R&D spending are driving the global high throughput screening industry. In addition, demand development is projected to be powered by the growing research activities in stem cells & toxicology and emerging markets. In recent years, technological developments such as liquid handling automation, the development of novel technology systems, and computational methods to deal with vast volumes of data have increasingly powered the global demand for high-performance screening instruments. Rising rivalry for pioneering drug development and marketing demand for high-performance screening instruments among pharmaceutical firms is growing at a rapid rate.

Strong capital spending, on the other hand, is expected to hamper demand growth during the projected period. In addition, the high time consumption and high cost of high-throughput screening techniques can impede the growth of the market.

Segmental Analysis

Based on product & service, technology, applications, end user, and region, the global high throughput screening market has been segmented.

The global market has been bifurcated into reagents & assay kits, instruments, consumables & accessories, software and services, based on product & service.

Due to the large number of reagents and assay kits used in HTS techniques and increased government funding for life science research, the reagents & assay kits segment is expected to hold a significant share in the market.

Segmental Analysis

The worldwide market is divided into cell-based assays, 2D cell culture, 3D cell culture, 3D cell culture, perfusion cell culture, laboratory-on-a-chip (LOC), ultra-high-throughput screening, bioinformatics, and label-free technology based on technology.

Based on use, the global market is segmented into target recognition & confirmation, primary and secondary screening, toxicology assessment, and others. Due to rising pharmaceutical R&D and the increasing prevalence of many diseases, the application category is projected to be the fastest-growing.

The global market is categorised into pharmaceutical and biotechnology firms, university and government agencies, contract research organisations, and others, depending on end users.

Regional Overview

North America and Latin America have been segmented into the high-performance scanning industry in the Americas, with the North American market split into the US and Canada.

Due to the rising per capita healthcare spending and the fast penetration of advanced technologies in the region, the demand in the Americas is projected to dominate the global high throughput screening market. It is expected that the will adoption of HTS in the US and Canada will fuel the growth of the sector. In addition, growing spending on research by healthcare institutions is expected to boost demand growth in this field.

In Europe, the market was projected to see a substantial amount of growth. The existence of a well-established healthcare sector and the participation of main corporations can be attributed to this.

Leading to a rise in chronic diseases and rising government measures for health care reforms, the Asia-Pacific market is expected to have a steady growth rate during the forecast period.

The Middle East & Africa market is estimated to account for the lowest share of the global market because of the region's low per capita disposable income.

Competitive Dashboard

The key players operating in the global high throughput screening market research are Aurora Biomed Inc. (Canada), Danaher (US), PerkinElmer (US), Tecan (Switzerland), Hamilton (US), Axxam (Italy), Merck Group (Germany), Corning (US), BioTek (US), Beckman Coulter, Inc. (US), Agilent Technologies Inc. (US), Luminex Corporation (US), and Roche (Switzerland).

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com

[industrytrends1]

Why Are Hospitals Purchasing High-Slice CT Scanners despite Their High Costs?

As per the World Health Organization (WHO), 17.9 million people die of heart diseases and 9.6 million of cancer each year. Those who succumb to or survive such diseases experience long-term discomfort, and the quality of their life is severely destroyed. Hence, the focus of the global healthcare fraternity on their effective diagnosis, so that the appropriate care regimen can be initiated, is rising. A variety of tests are done at hospitals and diagnostic centers for the detection, staging, and treatment evaluation for these and many other diseases.

Therefore, with the rising number of people requiring diagnostic tests, the computed tomography (CT) market is expected to witness a steady 5.0% CAGR between 2016 and 2022, since generating $4,894.3 million in 2015, according to P&S Intelligence. A CT machine is one of the most-useful tools at medical centers to scan the insides of the body. It uses X-rays to create pictures of bones, muscles, tissues, organs, and blood vessels, so that the issues related to them can be identified.

One of the main purposes a CT is used for is looking for internal trauma, such as internal bleeding and brain injuries. As per the WHO, almost 1.3 million people die of road accidents each year. Since road accidents lead to some of the nastiest injuries, CTs are extensively used in emergency settings to evaluate the condition of the victim. In such places, where time is short, a CT is usually preferred over a magnetic resonance imaging (MRI) scan, as the former can generate images within minutes, while an MRI can take up to 40 minutes to create images.

Apart from helping in the diagnosis, CTs also help doctors in assessing the effect of treatments and in several medical procedures. For instance, minimally invasive surgeries (MIS), which are becoming increasingly common with time, are centered on the principle of as minute incisions as possible. But, as the doctor still needs to see inside the body, CTs can be used to guide the surgeon. Similarly, CT-guided biopsies and radiation therapies are also increasing in volume, especially with the rising incidence of cancer.

When doing a CT, a key term radiologists use is ‘slice’. CT scanners can range from one to 320 slices! A slice is the number of layers the scanner can break the body into. It is literally like slicing a loaf of bread to check if it has gone bad inside. How many slices a CT should have is a matter of debate, with some radiologists insisting that a cost-effective 64-slice CT is as good (for cardiac diagnosis) as an expensive 256-slice variant.

However, the demand for high-slice CTs is still expected to increase fast in the coming years, as their potential usage for more applications than before is evaluated. For instance, owing to their ability to scan the entire heart in 0.5 seconds, 320-slice CTs might be a better option for cardiac perfusion imaging than 64-slice variants and for adenosine stress imaging, currently done by MRIs and positron emission tomography (PET) systems. For the same reason, high-slice CTs could also be used for the perfusion imaging of the brain and liver, thus allowing multiple departments of a hospital to share one system.

Presently, North America is the most-productive computed tomography market on account of the rising incidence of chronic diseases, especially heart diseases and cancer, booming geriatric population, increasing healthcare spending, and improving healthcare facilities. Apart from North America, the demand for CT systems is set to grow rapidly in Asia-Pacific (APAC) in the future, due to almost the same reasons. Moreover, to offer quality healthcare, governments of APAC countries are taking measures to construct new hospitals and procure advanced CT machines and other systems.

Thus, as the awareness regarding the early and effective diagnosis of diseases increases, so will the procurement of CT systems by medical centers around the world.

[insightslicelive]

Perfusion Systems Market Regional Growth Drivers, Opportunities and Trends 2021-2031

Perfusion Systems Market Regional Growth Drivers, Opportunities and Trends 2021-2031

  insightSLICE offers overarching research and analysis-based study on, “Global Perfusion Systems Market 2021-2031 the research report explores the analysis of historical data along with size, share, growth, demand, and revenue of the Perfusion Systems and estimates the future trend of the market on the basis of this detailed study. The study shares market performance both in terms of volume and…